AF w/AS 550 x 1-14ML/HR CPNB, Product code MVBXL- CPNB, Arrow AutoFuser Disposable Pain Control Pump
FDA Device Recall #Z-0940-2019 — Class II — October 2, 2018
Recall Summary
| Recall Number | Z-0940-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 2, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Arrow International Inc |
| Location | Reading, PA |
| Product Type | Devices |
| Quantity | 38 |
Product Description
AF w/AS 550 x 1-14ML/HR CPNB, Product code MVBXL- CPNB, Arrow AutoFuser Disposable Pain Control Pump
Reason for Recall
Possible cracks on the body of the fill port connector, which may result in a leak. If the leak is identified while the user is filling the pump, there may be a delay while an alternative pump is located. If the leak goes undetected it may result in a reduced level of drug delivery to the patient and consequently a lower level of pain relief than that prescribed or expected. This may result in the need for other, additional analgesic drug administration.
Distribution Pattern
Nationwide distribution.
Lot / Code Information
74A1801376 74G1702799 74A1801900 74H1700167 74A1802544 74H1701111 74B1700925 74H1701796 74C1701765 74H1702406 74D1700392 74J1700193 74D1701253 74J1700680 74D1701539 74J1701583 74D1702241 74J1702180 74E1700485 74J1702742 74E1701026 74K1700635 74E1701692 74K1701435 74E1702410 74K1702040 74F1700147 74K1702604 74F1701966 74L1700203 74F1702681 74L1700932 74F1703240 74L1702112 74G1700539 74M1700833 74G1701226 74M1701615
Other Recalls from Arrow International Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0231-2022 | Class I | Arrow-Trerotola Over-The-Wire PTD Kit Percutane... | Sep 20, 2021 |
| Z-0232-2022 | Class I | Arrow-Trerotola Over-The-Wire PTD Kit Percutane... | Sep 20, 2021 |
| Z-0234-2022 | Class I | Arrow-Trerotola Over-The-Wire PTD Kit Percutane... | Sep 20, 2021 |
| Z-0233-2022 | Class I | Arrow-Trerotola Over-The-Wire PTD Kit Percutane... | Sep 20, 2021 |
| Z-2071-2021 | Class II | Arrow Temporary Pacing Catheter/Introducer Kit ... | May 19, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.